Perfil
Michael Listgarten is General Counsel at ALX Oncology Holdings, Inc. since 2026.
Formerly, General Counsel at Rapt Therapeutics, Inc. from 2023 to 2026, Vice President-Healthcare Law at Principia Biopharma, Inc. in 2020, and VP-Healthcare Law & Chief Compliance Officer at Adamas Pharmaceuticals LLC in 2021.
Education includes graduate studies at The Trustees of Columbia University in The City of New York and undergraduate studies at the University of Pennsylvania.
Cargos activos de Michael Listgarten
| Empresas | Cargo | Inicio |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Consejero General | 30/06/2026 |
Antiguos cargos conocidos de Michael Listgarten.
| Empresas | Cargo | Fin |
|---|---|---|
| RAPT THERAPEUTICS, INC. | Consejero General | 03/03/2026 |
| ADAMAS PHARMACEUTICALS, INC. | Oficial de Cumplimiento | 01/11/2021 |
| PRINCIPIA BIOPHARMA INC. | Corporate Officer/Principal | 01/12/2020 |
Formación de Michael Listgarten.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Principia Biopharma, Inc.
Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rapt Therapeutics, Inc.
Rapt Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oral small molecule therapies for patients | Health Technology |
ALX Oncology Holdings, Inc.
ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
- Bolsa de valores
- Insiders
- Michael Listgarten
















